Michael-Rock Goldsmith
Co-founder & Chief Innovation Scientist at Congruence Therapeutics Inc.
- Role
- Co-founder & Chief Innovation Scientist at Congruence Therapeutics
- Location
- Durham, NC, US
- LinkedIn followers
- 500 followers
About Michael-Rock Goldsmith
Specialties: docking, QSAR, conformational analysis, vHTS, computational/predictive toxicology, product engineering, formulation and kinetic optimization/design, scientific computing, ecological epidemiology, passive interrogation, computational discovery chemistry for biologically active small molecules
Experience
Co-founder & Chief Innovation Scientist
May 2021 — Present · Raleigh-Durham-Chapel Hill, NC, US
Congruence Therapeutics is a biotechnology company using a unique computational platform to develop pharmacological stabilizers for rare diseases.
Education
Duke University
Ph.D., Computational Chemistry
2001 — 2005
Concordia University
B.Sc. Honors - CO-OP, Chemistry
1995 — 1998
Marianopolis College
DEC, Health Sciences
1993 — 1995
Lower Canada College
Secondary School Diploma
1985 — 1993
Skills
- Computational Toxicology
- Molecular Modeling
- Environmental Toxicology
- Qsar
- Scientific Computing
- Docking
- Hts
- Product Engineering
- Toxicology
- High Throughput Screening
- Biochemistry
- Genomics
- In Vitro
- Bioinformatics
- Adme
- Drug Discovery
- Science
- Predictive Modeling
- Computational Biology
- Computational Chemistry
- Chemistry
- Protein Chemistry
- In Vivo
- Characterization
- Medicinal Chemistry
- Laboratory
- Life Sciences
- Biotechnology
Find verified contacts for anyone on LinkedIn
Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.
Free plan included · No credit card required
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.